期刊文献+

经皮椎体后凸成形术与经皮椎体成形术治疗骨质疏松性椎体压缩骨折患者的效果比较 被引量:7

Comparison of effects of percutaneous kyphoplasty and percutaneous vertebroplasty in treatment of patients with osteoporotic vertebral compression fractures
下载PDF
导出
摘要 目的:比较经皮椎体后凸成形术(PKP)与经皮椎体成形术(PVP)治疗骨质疏松性椎体压缩骨折(OVCF)患者的效果。方法:回顾性分析2018年2月至2022年3月该院收治的98例OVCF患者的临床资料,按照手术方法不同将其分为观察组与对照组各49例。对照组行PVP治疗,观察组行PKP治疗。比较两组手术相关指标(透视次数、手术时间、骨水泥用量、治疗费用)水平、手术前后椎体功能[Oswestry功能障碍指数(ODI)]评分、影像学指标(Cobb角、伤椎前缘高度比)水平、疼痛介质指标[神经肽Y(NPY)、P物质、前列腺素E_(2)(PGE_(2))]水平和并发症发生率。结果:观察组透视次数、骨水泥用量、治疗费用均多于对照组,手术时间长于对照组,差异有统计学意义(P<0.05);术后1、3个月,观察组ODI评分低于对照组,Cobb角小于对照组,伤椎前缘高度比大于对照组,差异有统计学意义(P<0.05);术后7 d,观察组P物质、NPY、PGE_(2)水平均低于对照组,差异有统计学意义(P<0.05);观察组并发症发生率为2.04%(1/49),低于对照组的16.33%(8/49),差异有统计学意义(P<0.05)。结论:PKP治疗OVCF患者可降低疼痛介质指标水平、ODI评分和并发症发生率,改善影像学指标水平,效果优于PVP治疗效果,但需增加透视次数、骨水泥用量、治疗费用和手术时间。 Objective:To compare effects of percutaneous kyphoplasty(PKP)and percutaneous vertebroplasty(PVP)in treatment of patients with osteoporotic vertebral compression fractures(OVCF).Methods:The clinical data of 98 patients with OVCF admitted to the hospital from February 2018 to March 2022 were retrospectively analyzed.They were divided into observation group and control group according to different surgical methods,49 cases in each.The control group was treated with PVP,while the observation group was treated with PKP.The operation related index levels(number of fluoroscopy,operation time,bone cement dosage,treatment cost),the vertebral function[Oswestry dysfunction index(ODI)]score before and after the surgery,the imaging index levels(Cobb angle,anterior vertebral height ratio of injured vertebral body),the pain mediator levels[neuropeptide Y(NPY),substance P,prostaglandin E_(2)(PGE_(2))],and the incidence of complications were compared between the two groups.Results:The number of fluoroscopy,the bone cement dosage and the treatment cost in the observation group were more than those in the control group,the operation time was longer than that in the control group,and the differences were statistically significant(P<0.05).1 and 3 months after the surgery,the ODI scores of the observation group were lower than those of the control group,the Cobb angle was smaller than that of the control group,the anterior vertebral height ratio was higher than that of the control group,and the differences were statistically significant(P<0.05).7 days after the surgery,the levels of substance P,NPY and PGE_(2) in the observation group were lower than those in the control group,and the differences were statistically significant(P<0.05).Further,the incidence of complications in the observation group was 2.04%(1/49),which was lower than 16.33%(8/49)in the control group,and the difference was statistically significant(P<0.05).Conclusions:PKP in the treatment of the OVCF patients can reduce the levels of pain mediators,the ODI scores and the incidence of complications,and improve the levels of imaging indicators.It is superior to PVP.However,the number of fluoroscopy,the bone cement dosage,the treatment cost and the operation time can be increased.
作者 张晨冲 李沙 王忠仁 ZHANG Chenchong;LI Sha;WANG Zhongren(Department of Spinal Surgery of Jiaozuo People’s Hospital,Jiaozuo 454000 Henan,China)
出处 《中国民康医学》 2023年第10期152-155,共4页 Medical Journal of Chinese People’s Health
关键词 骨质疏松性椎体压缩骨折 经皮椎体后凸成形术 经皮椎体成形术 疼痛介质 椎体功能 并发症 Osteoporotic vertebral compression fracture Percutaneous kyphoplasty Percutaneous vertebroplasty Pain mediator Vertebral function Complication
  • 相关文献

参考文献8

二级参考文献92

  • 1Ferno Ruiz Santiago,Alicia Santiago Chinchilla,Luis Guzmán álvarez,Antonio Luis Pérez Abela,Maria del Mar Castellano García,Miguel Pajares López.Comparative review of vertebroplasty and kyphoplasty[J].World Journal of Radiology,2014,6(6):329-343. 被引量:31
  • 2Wang G,Yang H,Chen K.Osteoporotic vertebral compression fractures with an intravertebral cleft treated by percutaneous balloon kyphoplasty.J Bone Joint Surg Br,2010,92(11):1553-1557.
  • 3Mao H,Zou J,Geng D,et al.Osteoporotic vertebral fractures without compression:key factors of diagnosis and initial outcome of treatment with cement augmentation.Neuroradiology,2012,54(10):1137-1143.
  • 4Parker M,Johansen A.Hip fracture.BMJ,2006,333(7557):27-30.
  • 5L?nnroos E,Kautiainen H,Karppi P,et al.Incidence of second hip fractures.A population-based study.Osteoporos Int,2007,18(9):1279-1285.
  • 6Black DM,Delmas PD,Eastell R,et al.Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.N Engl J Med,2007,356(18):1809-1822.
  • 7Black DM,Reid IR,Boonen S,et al.The effect of 3 versus6 years of zoledronic acid treatment of osteoporosis:a randomized extension to the HORIZON-Pivotal Fracture Trial(PFT).J Bone Miner Res,2012,27(2):243-254.
  • 8Black DM,Reid IR,Cauley JA,et al.The effect of 6 versus9 years of zoledronic acid treatment in osteoporosis:a randomized second extension to the HORIZON-Pivotal Fracture Trial(PFT).J Bone Miner Res,2015,30(5):934-944.
  • 9Lyles KW,Colón-Emeric CS,Magaziner JS,et al.Zoledronic acid and clinical fractures and mortality after hip fracture.N Engl J Med,2007,357(18):1799-1809.
  • 10Black DM,Schwartz AV,Ensrud KE,et al.Effects of continuing or stopping alendronate after 5 years of treatment:the Fracture Intervention Trial Long-term Extension(FLEX):a randomized trial.JAMA,2006,296(24):2927-2938.

共引文献507

同被引文献111

引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部